PL1704860T3 - Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki - Google Patents

Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki

Info

Publication number
PL1704860T3
PL1704860T3 PL05102423T PL05102423T PL1704860T3 PL 1704860 T3 PL1704860 T3 PL 1704860T3 PL 05102423 T PL05102423 T PL 05102423T PL 05102423 T PL05102423 T PL 05102423T PL 1704860 T3 PL1704860 T3 PL 1704860T3
Authority
PL
Poland
Prior art keywords
mucositis
benzamidine derivatives
prevention
treatment
epitelium
Prior art date
Application number
PL05102423T
Other languages
English (en)
Polish (pl)
Inventor
Ornella Letari
Massimo Maria D'amato
Simona Zanzola
Roberto Artusi
Lucio Claudio Rovati
Gianfranco Caselli
Antonio Giordani
Original Assignee
Rottapharm Biotech Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Biotech Srl filed Critical Rottapharm Biotech Srl
Publication of PL1704860T3 publication Critical patent/PL1704860T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
PL05102423T 2005-03-24 2005-03-24 Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki PL1704860T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102423A EP1704860B1 (fr) 2005-03-24 2005-03-24 Des dérivés de la benzamidine pour le traitement et la prophylaxie de la mucositis

Publications (1)

Publication Number Publication Date
PL1704860T3 true PL1704860T3 (pl) 2011-04-29

Family

ID=35058092

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05102423T PL1704860T3 (pl) 2005-03-24 2005-03-24 Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki

Country Status (13)

Country Link
US (1) US20080194877A1 (fr)
EP (1) EP1704860B1 (fr)
JP (1) JP5020227B2 (fr)
AT (1) ATE485819T1 (fr)
AU (1) AU2006226390B2 (fr)
CA (1) CA2600773C (fr)
DE (1) DE602005024357D1 (fr)
DK (1) DK1704860T3 (fr)
ES (1) ES2351665T3 (fr)
HK (1) HK1095285A1 (fr)
PL (1) PL1704860T3 (fr)
PT (1) PT1704860E (fr)
WO (1) WO2006100204A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
CN103957710B (zh) 2011-05-16 2016-04-20 塞尔西优蒂克斯公司 用于治疗粘膜炎的化合物
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
SG11201407326XA (en) * 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of mucositis
US20160199338A1 (en) 2013-08-19 2016-07-14 Enzychem Lifesciences Corporation Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis
CN106535887A (zh) 2014-05-15 2017-03-22 株式会社Enzychem生命科学 治疗白细胞减少症和血小板减少症的方法
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
WO2021248008A1 (fr) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Composés arylamides pour le traitement et la prévention d'infections virales
CA3220039A1 (fr) 2021-06-14 2022-12-22 Jr. David St. Jean Derives d'uree pouvant etre utilises pour traiter le cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458777B1 (en) * 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
ITTO20010110A1 (it) * 2001-02-08 2002-08-08 Rotta Research Lab Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.

Also Published As

Publication number Publication date
CA2600773C (fr) 2013-06-11
ES2351665T3 (es) 2011-02-09
US20080194877A1 (en) 2008-08-14
JP5020227B2 (ja) 2012-09-05
EP1704860B1 (fr) 2010-10-27
JP2008534471A (ja) 2008-08-28
DE602005024357D1 (de) 2010-12-09
ATE485819T1 (de) 2010-11-15
EP1704860A1 (fr) 2006-09-27
CA2600773A1 (fr) 2006-09-28
AU2006226390A1 (en) 2006-09-28
DK1704860T3 (da) 2011-02-07
HK1095285A1 (en) 2007-05-04
AU2006226390B2 (en) 2011-09-08
PT1704860E (pt) 2010-11-16
WO2006100204A1 (fr) 2006-09-28

Similar Documents

Publication Publication Date Title
HK1095285A1 (en) Benzamidine derivatives for treatment and prevention of mucositis
WO2004093831A3 (fr) Combinaisons de vaccins cellulaires exprimant les cytokines
WO2004073630A3 (fr) Proprietes anti-angiogeniques et antitumorales des inhibiteurs de beta-secretase et de gamma-secretase
HK1112579A1 (en) Dosage regimen for the treatment of a traumatic brain injury with progesterone
WO2016025635A3 (fr) Polythérapie pour le traitement du cancer
IL190295A0 (en) Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders
AU2003249356A8 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
WO2000035475A3 (fr) Methode de traitement des ischemies cerebrales et utilisation de l&#39;erythropoietine ou de derives de l&#39;erythropoietine pour traiter les ischemies cerebrales
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
WO2004096216A3 (fr) Utilisation de riluzole dans le traitement de maladies caracterisees par l&#39;hyperproliferation de keratinocytes, en particulier la dermatite atopique et le psoriasis
WO2016043874A3 (fr) Polythérapie pour le traitement du cancer
EP4327873A3 (fr) Formulations de tpp1 et méthodes de traitement de la maladie cln2
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a C5-related disease and a method for the treatment or prevention of a C5-related disease
IL307201A (en) Triazine derivatives and their use in cancer treatment.
EP1865954A4 (fr) Methodes pour eviter un oedeme dans le traitement ou la prevention de maladies sensibles a ppar gamma, telles que le cancer
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
WO2008045378A3 (fr) Traitement d&#39;hyperbilirubinémie infantile en utilisant des faibles dosages de stannsoporfine
BRPI0503827A (pt) métodos para prevenir ou tratar infecções respiratórias em lactentes
IL282718A (en) Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
GB0427637D0 (en) Topical formulations for use in the treatment or prevention of skin cancers
TW200509925A (en) Method comprising irinotecan for treatment of breast cancer
IL197035A0 (en) Pharmaceutical formula for treating skin disease
AU2003265321A8 (en) Treatments and methods for the treatment, diagnosis and prophylaxis
IL189301A0 (en) Pneumatic therapeutic system for preventing and/or treating bedsores and stimulating blood circulation